| In EUR m | Q2 2024 | Q2 2023 | 6M 2024 | 6M 2023 |
| Revenue | 511.5 | 454.8 | 965.0 | 864.7 |
| EBITDA (adjusted) | 154.9 | 130.0 | 263.3 | 227.2 |
| Exceptional items | -3.5 | -1.5 | -8.2 | -4.3 |
| EBITDA | 151.4 | 128.6 | 255.1 | 222.9 |
| Amortization, depreciation and impairment | -79.7 | -76.7 | -156.6 | -152.7 |
| thereof attributable to purchase price allocations and impairment losses | -3.2 | -4.8 | -6.4 | -9.8 |
| EBIT | 71.7 | 51.9 | 98.5 | 70.2 |
| Net finance income/costs | -17.9 | -14.7 | -36.2 | -28.4 |
| EBT | 53.7 | 37.2 | 62.3 | 41.9 |
| Taxes | -16.2 | -10.3 | -18.8 | -11.5 |
| Consolidated profit or loss for the period | 37.5 | 26.9 | 43.5 | 30.3 |
| Adjusted consolidated profit or loss for the period | 42.3 | 31.2 | 54.8 | 40.0 |
| Free cash flow (before M&A transactions) | 97.1 | 56.0 | 121.6 | 77.3 |
| Free cash flow (before M&A transactions)(adjusted) | 46.1 | -1.1 | 21.7 | -15.6 |
| Net debt (Jun. 30/Dec. 31) | 843.8 | 770.0 |
